PRDM9 and glioblastoma: Nevertheless, in all models, cholesterol supplementation rescued the anti-persister effects of the PRDM9 inhibitor MRK-740, supporting a broader role for PRDM9 in regulating cholesterol biosynthesis and persisters survival across glioblastoma models.